The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies

被引:11
作者
Guo, Haochuan [1 ]
Xu, Xinru [1 ]
Zhang, Jiaxi [1 ]
Du, Yajing [1 ]
Yang, Xinbing [1 ]
He, Zhiheng [2 ,3 ]
Zhao, Linjie [2 ,3 ]
Liang, Tingming [1 ]
Guo, Li [2 ,3 ]
机构
[1] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Peoples R China
[2] Nanjing Univ Posts & Telecommun, State Key Lab Organ Elect & Informat Displays, 9 Wenyuan Rd, Nanjing 210023, Peoples R China
[3] Nanjing Univ Posts & Telecommun, Inst Adv Mat IAM, 9 Wenyuan Rd, Nanjing 210023, Peoples R China
基金
中国国家自然科学基金;
关键词
preclinical animal models; anti-cancer therapy; drug development; personalized therapy; REPEAT-DOSE TOXICITY; MOUSE MODELS; GENOMIC INSTABILITY; CYNOMOLGUS MONKEY; CARCINOGENICITY; HALLMARKS; SAFETY; REQUIREMENTS; GENERATION; CHALLENGES;
D O I
10.3390/ph17081048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The establishment and utilization of preclinical animal models constitute a pivotal aspect across all facets of cancer research, indispensably contributing to the comprehension of disease initiation and progression mechanisms, as well as facilitating the development of innovative anti-cancer therapeutic approaches. These models have emerged as crucial bridges between basic and clinical research, offering multifaceted support to clinical investigations. This study initially focuses on the importance and benefits of establishing preclinical animal models, discussing the different types of preclinical animal models and recent advancements in cancer research. It then delves into cancer treatment, studying the characteristics of different stages of tumor development and the development of anti-cancer drugs. By integrating tumor hallmarks and preclinical research, we elaborate on the path of anti-cancer drug development and provide guidance on personalized cancer therapy strategies, including synthetic lethality approaches and novel drugs widely adopted in the field. Ultimately, we summarize a strategic framework for selecting preclinical safety experiments, tailored to experimental modalities and preclinical animal species, and present an outlook on the prospects and challenges associated with preclinical animal models. These models undoubtedly offer new avenues for cancer research, encompassing drug development and personalized anti-cancer protocols. Nevertheless, the road ahead continues to be lengthy and fraught with obstacles. Hence, we encourage researchers to persist in harnessing advanced technologies to refine preclinical animal models, thereby empowering these emerging paradigms to positively impact cancer patient outcomes.
引用
收藏
页数:30
相关论文
共 50 条
[41]   Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy [J].
Jo, Ukhyun ;
Kim, Hyungjin .
MOLECULES AND CELLS, 2015, 38 (08) :669-676
[42]   Bisindolylmaleimides in anti-cancer therapy - more than PKC inhibitors [J].
Pajak, B. ;
Orzechowska, S. ;
Gajkowska, B. ;
Orzechowski, A. .
ADVANCES IN MEDICAL SCIENCES, 2008, 53 (01) :21-31
[43]   The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models [J].
Teixeira, Silvia A. ;
Luzzi, Mayara de Cassia ;
Baptista Moreno Martin, Ana Carolina ;
Duarte, Terence Teixeira ;
Leal, Monica de Oliveira ;
Teixeira, Gustavo Ramos ;
Reis, Monise Tadin ;
Almeida Junior, Carlos Roberto ;
Santos, Karina ;
Melendez, Matias Eliseo ;
Silveira Alves da Silva, Diego da Cunha ;
Bernecule, Priscila Neves ;
Lourenco Firmino, Higor Vinicius ;
Vieira Alves, Ana Laura ;
Guimaraes, Denise Peixoto ;
Borduqui, Joao Vitor ;
Laus, Ana Carolina ;
Mancano, Bruna Minniti ;
Reis, Rui Manuel .
VETERINARY SCIENCES, 2022, 9 (11)
[44]   Investigation of the female infertility risk associated with anti-cancer therapy [J].
Lavafian, Atiye ;
Pezeshki, Parmida Sadat ;
Rezaei, Nima .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (07) :1893-1905
[45]   Investigation of the female infertility risk associated with anti-cancer therapy [J].
Atiye Lavafian ;
Parmida Sadat Pezeshki ;
Nima Rezaei .
Clinical and Translational Oncology, 2023, 25 :1893-1905
[46]   Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies [J].
Zinovieva, Margarita ;
Ryapolova, Anastasia ;
Karabelsky, Alexander ;
Minskaia, Ekaterina .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (11)
[47]   State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL [J].
Bernardi, Stella ;
Secchiero, Paola ;
Zauli, Giorgio .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2012, 7 (02) :207-217
[48]   Role of artificial intelligence in cancer drug discovery and development [J].
Sarvepalli, Sruthi ;
Vadarevu, ShubhaDeepthi .
CANCER LETTERS, 2025, 627
[49]   Berberine as a Promising Safe Anti-Cancer Agent - Is there a Role for Mitochondria? [J].
Diogo, Catia V. ;
Machado, Nuno G. ;
Barbosa, Ines A. ;
Serafim, Teresa L. ;
Burgeiro, Ana ;
Oliveira, Paulo J. .
CURRENT DRUG TARGETS, 2011, 12 (06) :850-859
[50]   Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products [J].
Su, Zhengxing ;
Zhao, Jinlong ;
Zhao, Xi ;
Xie, Jia ;
Li, Ming ;
Zhao, Dong .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 635